Patent · US Expired

6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds

US4521415A · kind A · utility

15Cited by
1References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 1982
Grant dateJun 4, 1985
Priority date
Expiry dateDec 28, 2002

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds possessing strong platelet aggregation inhibiting activity and blood pressure depressing activity, having the general formula: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl; R.sup.2 is hydrogen, lower alkyl, lower alkylthio or the grouping R.sup.5 --NH-- where R.sup.5 is lower alkyl; R.sup.3 is phenyl, pyridyl, benzyl, lower alkyl or a substituted phenyl group carrying at any desired position on the benzene ring thereof the grouping: ##STR2## where R.sup.1 has the same meaning as given above; R.sup.4 is hydrogen or halogen; n is 0 or 1; and when both R.sup.2 and R.sup.3 are lower alkyl groups, R.sup.2 and R.sup.3 may be combined together with the bridging member ##STR3## where m is 2 or 3, as well as physiologically acceptable acid-addition salts thereof, and processes for preparing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.